Panion presented at InvestorDagen in Århus, Denmark, the 12.th of June 2018.
The progress and plans for Panion’s development of the gene therapy treatment for dogs with epilepsy, and for Panion’s business idea and vision, was presented by Anja Holm, CEO of Panion, at the InvestorDagen event in Århus, Denmark on the 12.th of June.
A webcast of the presentation can be found here (in Danish): https://getvisualtv.net/stream/?daf-investordagen-aarhus-120618#panion-animal-health
“The day was well-attended with approximately 500 visitors for the entire event, and I experienced good interest for Panion’s unique product development and for the presentation. Most people own dogs or cats and can easily understand the willingness to pay for treatments when the pets are seriously ill”, says Anja Holm. “It was very satisfying to talk with both existing shareholders and new, interested persons during the day. AktieTorget will enter the Danish market later this year, so we find it very relevant to reach out to interested investors in Denmark.”
InvestorDagen, Dansk Aktionærforening, @Shareholders.dk
Anja E. H. Holm, CEO
+ 45-22 94 66 00
Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.